TAILIEUCHUNG - IMPLEMENTING A NATIONAL CANCER CLINICAL TRIALS SYSTEM FOR THE 21ST CENTURY_1

Clinical trials enable scientific discoveries to advance patient care, and they also inform and guide subsequent research. The National Cancer Institute (NCI) supports the largest . network of clinical trials of any type, of which the largest component is the Clinical Trials Cooperative Group Program (informally known as the Cooperative Group Program). It currently comprises 10 Groups that involve more than 3,100 institutions and 14,000 investigators who enroll more than 25,000 patients in clinical trials each year. Since its inception in the 1950s, the Cooperative Group Program has been instrumental in establishing the standards for cancer patient care and clinical research methods. Research performed by the Cooperative Groups has significantly. | IMPLEMENTING A NATIONAL CANCER CLINICAL TRIALS SYSTEM FOR THE 21ST CENTURY INSTITUTE OF MEDICINE O rur AfAXMVJ IMPLEMENTING A NATIONAL CANCER CLINICAL TRIALS SYSTEM FOR THE 21st century Workshop Summary An American Society of Clinical Oncology and Institute of Medicine Workshop Alison Mack and Sharyl J. Nass Rapporteurs National Cancer Policy Forum Board on Health Care Services INSTITUTE OF MEDICINE OF THE NATIONAL ACADEMIES THE NATIONAL ACADEMIES PRESS Washington . THE NATIONAL ACADEMIES PRESS 500 Fifth Street . Washington DC 20001 NOTICE The project that is the subject of this report was approved by the Governing Board of the National Research Council whose members are drawn from the councils of the National Academy of Sciences the National Academy of Engineering and the Institute of Medicine. The members of the committee responsible for planning the workshop were chosen for their special competences and with regard for appropriate balance. This project was sponsored by the American Society of Clinical Oncology. The National Cancer Policy Forum is supported by Contract Nos. HHSN261200900003C and 2002005-13434 TO 1 between the National Academy of Sciences and the National Cancer Institute and the Centers for Disease Control and Prevention respectively. This project was also supported by the American Association for Cancer Research the American Cancer Society the Association of American Cancer Institutes Bristol-Myers Squibb C-Change the CEO Roundtable on Cancer Novartis Oncology and the Oncology Nursing Society. Any opinions findings conclusions or recommendations expressed in this publication are those of the author s and do not necessarily reflect the view of the organizations or agencies that provided support for this project. International Standard Book Number-13 978-0-309-21268-7 International Standard Book Number-10 0-309-21268-5 Additional copies of this report are available from the National Academies Press 500 Fifth Street . Lockbox .

• Y học thường thức
• Clinical Oncology
• NCI Community
• Panel Discussion
• Medicaid Support
• Clinical Trials
• Informed Consent
• Vendor Perspective
• Manual of clinical oncology
• Nuclear medicine
• Radiation oncology
• Systemic therapy agents
• Cancer immunotherapy
• Cancer survivorship
• Lung cancer
• Miscellaneous neoplasms
• Chronic leukemias
• Acute leukemia
• Cutaneous complications
• Abdominal complications
• BMC Cancer
• Oncology clinical trial drug interaction
• Drug drug interactions
• Clinically relevant DDI
• Adequately screen
• Oncology pharmacotherapy
• Drug indications
• Clinical support tool
• Hospital at home care
• Oncology care at home
• Supportive oncology care at home
• Treatment toxicities
• Building Bridges
• Medicine Symposium
• Cancer Survivor
• coordinating care
• Cancer Care
• Gynecologic oncology clinical practice
• Surgical atlas
• Critical care
• Staging procedures
• Cytoreductive procedures
• Minimally invasive surgery
• Clinical ophthalmic oncology
• Examination techniques
• Differential diagnosis
• Benign orbital tumors
• Optic nerve tumors
• Orbital vascular tumors
• Lacrimal gland tumors
• Lacrimal sac tumors
• Adnexal lymphoma
• Malignant orbital tumors
• Neuro oncology
• Radiomics analysis
• Radiomics quality score
• Clinical utility
• Performance index
• Health technology assessment
• Next generation sequencing
• Desired panel
• báo cáo khoa học
• báo cáo y học
• công trình nghiên cứu về y học
• tài liệu về y học
• cách trình bày báo cáo
• Pediatric patients undergoing radiotherapy
• Oncology centre
• Hue Central Hospital
• Clinical important complication
• Neurology during
• BMC Bioinformatics
• Biomedical information retrieval
• Document retrieval
• Personalized oncology
• Document classification
• Clinical relevance
• Document triage
• Clinical trial
• Phase 1
• Continual reassessment method
• Prior skeleton
• Clinical decision support systems
• Evidence based practice
• Cancer chemotherapy protocols
• Clinical oncology
• Health personnel
• Predictive Tests
• Increasing Complexity
• Clinical Implications
• Capture Clinical
• Value of Biomarkers
• Personalized Medicine
• A clinical approach to medicine
• Medical oncology
• Obstetrics and gynecology
• Tenal medicine
• Respiratory medicine
• Rehabilitative medicine
• Syngeneic model
• Mouse clinical trials
• Linear mixed models
• Survival analysis
• Statistical power
• Patient participation
• Controlled clinical trials
• Patient education
• Communication skills training
• Randomized clinical trials
• Physicians’ communication during